Completed NA INTERVENTIONAL 1-arm NCT04104633

Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the Massive Parallel Sequencing on Circulating Tumor DNA

Sponsor: Centre Hospitalier Henri Duffaut - Avignon

Conditions Breast Cancer Colo-rectal Cancer

Updated 7 times since 2019 Last updated: Jan 10, 2025 Started: Jun 14, 2018 Primary completion: Jun 1, 2021 Completion: Jun 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Colo-rectal Cancer and is currently completed. Centre Hospitalier Henri Duffaut - Avignon leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Feb 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Feb 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Oct 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Henri Duffaut - Avignon

Data source: Centre Hospitalier Henri Duffaut - Avignon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Avignon, France